Literature DB >> 20413727

Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms.

David J Kaczorowski1, Amin Afrazi, Melanie J Scott, Joon H Kwak, Roop Gill, Rebecca D Edmonds, Yujian Liu, Jie Fan, Timothy R Billiar.   

Abstract

TLRs and complement are critical to the host response in sepsis, trauma, and ischemia/reperfusion. We hypothesize that TLR stimulation leads to synthesis and release of complement components by macrophages, an important source of extrahepatic complement. RAW264.7 macrophages or peritoneal macrophages from WT and TLR4-, TLR3-, TRIF-, or MyD88-deficient mice were cultured under standard conditions. In some experiments, cells were pretreated with inhibitors of MAPKs or a NF-κB inhibitor. Cells were stimulated with TLR ligands at known stimulatory concentrations. Intratracheal and i.p. injections were also performed in mice. RT-PCR, Western blotting, and immunocytochemistry were used for analysis. Using a RT-PCR-based panel, we demonstrate that of 18 complement components tested, factor B of the alternative pathway is the most robustly up-regulated complement component in macrophages in response to LPS. This up-regulation results in release of factor B into the media. Up-regulation of factor B by LPS is dependent on TLR4, TRIF, JNK, and NF-κB. A screen of other TLR ligands demonstrated that stimulation with poly I:C (dsRNA analog) also results in up-regulation of factor B, which is dependent on JNK and NF-κB but independent of TLR3 and TRIF. Up-regulation of factor B is also observed after intratracheal and i.p. injection of LPS or poly I:C in vivo. PRR stimulation profoundly influences production and release of factor B by macrophages. Understanding the mechanisms of PRR-mediated complement production may lead to strategies aimed at preventing tissue damage in diverse settings, including sepsis, trauma, and ischemia/reperfusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413727      PMCID: PMC2974428          DOI: 10.1189/jlb.0809588

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  33 in total

1.  Complement factor B gene regulation: synergistic effects of TNF-alpha and IFN-gamma in macrophages.

Authors:  Yong Huang; Peter M Krein; Daniel A Muruve; Brent W Winston
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

2.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.

Authors:  H Watanabe; G Garnier; A Circolo; R A Wetsel; P Ruiz; V M Holers; S A Boackle; H R Colten; G S Gilkeson
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  Characterization of IFN-gamma regulation of the complement factor B gene in macrophages.

Authors:  Y Huang; P M Krein; B W Winston
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

5.  Arthritis critically dependent on innate immune system players.

Authors:  Hong Ji; Koichiro Ohmura; Umar Mahmood; David M Lee; Frans M A Hofhuis; Susan A Boackle; Kazue Takahashi; V Michael Holers; Mark Walport; Craig Gerard; Alan Ezekowitz; Michael C Carroll; Michael Brenner; Ralph Weissleder; J Sjef Verbeek; Veronique Duchatelle; Claude Degott; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

6.  Complement proteins and macrophages. II. The secretion of factor B by lipopolysaccharide-stimulated macrophages.

Authors:  A Miyama; Y Kawamoto; H Ichikawa; K Okamoto; S Hara; T Inoue
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

7.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

8.  Complement deficiency ameliorates collagen-induced arthritis in mice.

Authors:  Max Albert Hietala; Ing-Marie Jonsson; Andrej Tarkowski; Sandra Kleinau; Marcela Pekna
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

10.  Factor B, the complement alternative pathway serine proteinase, is a major constitutive protein synthesized and secreted by resident and elicited mouse macrophages.

Authors:  J S Sundsmo; J R Chin; R A Papin; D S Fair; Z Werb
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

2.  Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.

Authors:  Nagihan Bostanci; Kai Bao; Xiaofei Li; Tomoki Maekawa; Jonas Grossmann; Christian Panse; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Cristina A G Garcia; Edimara S Reis; John D Lambris; George Hajishengallis
Journal:  J Proteome Res       Date:  2018-08-29       Impact factor: 4.466

3.  Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis.

Authors:  Dan Li; Lin Zou; Yan Feng; Ganqiong Xu; Yu Gong; Gaofeng Zhao; Wen Ouyang; Joshua M Thurman; Wei Chao
Journal:  Crit Care Med       Date:  2016-05       Impact factor: 7.598

4.  Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice.

Authors:  Markus Huber-Lang; Andreas Barratt-Due; Søren E Pischke; Øystein Sandanger; Per H Nilsson; Miles A Nunn; Stephanie Denk; Wilhelm Gaus; Terje Espevik; Tom E Mollnes
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

5.  Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis.

Authors:  Lin Zou; Yan Feng; Yan Li; Ming Zhang; Chan Chen; Jiayan Cai; Yu Gong; Larry Wang; Joshua M Thurman; Xiaobo Wu; John P Atkinson; Wei Chao
Journal:  J Immunol       Date:  2013-10-23       Impact factor: 5.422

6.  Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.

Authors:  Qian Li; Yong Xing Li; Gregory L Stahl; Joshua M Thurman; Yujuan He; Hua Hua Tong
Journal:  Infect Immun       Date:  2011-04-18       Impact factor: 3.441

7.  Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.

Authors:  David J Kaczorowski; Melanie J Scott; John P Pibris; Amin Afrazi; Atsunori Nakao; Rebecca D Edmonds; Sodam Kim; Joon H Kwak; Yujian Liu; Jie Fan; Timothy R Billiar
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

Review 8.  More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.

Authors:  George Hajishengallis; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

9.  Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells.

Authors:  Sheila Cabezas; Gustavo Bracho; Amanda L Aloia; Penelope J Adamson; Claudine S Bonder; Justine R Smith; David L Gordon; Jillian M Carr
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

10.  Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.

Authors:  Sodam Kim; Sun Young Kim; John P Pribis; Michael Lotze; Kevin P Mollen; Richard Shapiro; Patricia Loughran; Melanie J Scott; Timothy R Billiar
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.